The cytochromes P450 (P450s) are a superfamily of oxidative haemoproteins that are capable of catalysing a vast range of oxidative transformations, including the oxidation of unactivated alkanes, often with high stereo-and regio-selectivity. Fatty acid hydroxylation by P450s is widespread across both bacteria and higher organisms, with the sites of oxidation and specificity of oxidation varying from system to system. Several key examples are discussed in the present article, with the focus on P450 BioI (CYP107H1), a biosynthetic P450 found in the biotin operon of Bacillus subtilis. The biosynthetic function of P450 BioI is the formation of pimelic acid, a biotin precursor, via a multiple-step oxidative cleavage of long-chain fatty acids. P450 BioI is a member of an important subgroup of P450s that accept their substrates not free in solution, but rather presented by a separate carrier protein. Structural characterization of the P450 BioI -ACP (acyl-carrier protein) complex has recently been performed, which has revealed the basis for the oxidation of the centre of the fatty acid chain. The P450 BioI -ACP structure is the first such P450-carrier protein complex to be characterized structurally, with important implications for other biosynthetically intriguing P450-carrier protein complexes.
for oxidation of substrates [4] . An excellent example of P450 diversity can be found in the oxidation of fatty acids, which, although appearing to be deceptively simple substrates, serve to highlight the biosynthetic ingenuity of Nature [5] .
Notable fatty-acid-hydroxylating P450s
A large number of P450s have been reported to catalyse the oxidation of fatty acids in vitro, including examples from bacteria, mammals and plants (for example, see [6] [7] [8] [9] ). Fatty acids are often used as one of a small number of potential substrates for the initial characterization of P450s, especially where the biological function is unclear, which can often lead to reports of P450 activity with fatty acids as a substrate where the true nature of the biologically relevant oxidation is unknown. A small selection of P450s showing activity at different parts of the fatty acid chain is discussed in the present paper, focusing on those where some type of structural or biochemical rationale exists for the selectivity of oxidation observed ( Figure 1 ).
Oxidation towards the methyl terminus: P450 BM3 (CYP102A1)
The most widely studied fatty-acid-metabolizing P450 is P450 BM3 (CYP102A1), isolated from Bacillus megaterium (a number of other P450s sharing similar features with P450 BM3 have been identified more recently in the CYP102 subfamily) [10] . P450 BM3 is one of a small subset of soluble P450s that are found to be expressed as a fusion protein, where the required redox partners are combined within a single polypeptide chain (the same as is observed with mammalian P450s) [4] . Turnover of fatty acids of C 12 -C 18 chain length has been reported with oxidation occurring at the sub-terminal methylene carbons of the fatty acid chain [11] . P450 BM3 is able to catalyse very rapid substrate turnover with a high degree of coupling (representing the efficiency of oxidation with regard to electrons received) and, as such, has been a target for many mechanistic and directed evolution studies [12] [13] [14] . The selectivity of oxidation of P450 BM3 normally covers three to five sub-terminal methylene carbons, with oxidation varying in distribution across these positions depending upon fatty acid chain length [11] . The stereochemical purity of the oxidations is high and favours R-hydroxylation, with the stereoselectivity decreasing with increasing distance from the methyl group [15] [16] [17] . Selectivity of oxidation can be improved with the incorporation of functionality within the fatty acid chain; methyl-branched iso-and anteio-fatty acids show vastly improved regiochemical selectivity over their unbranched counterparts [18] . In addition, the oxidation of unsaturated fatty acids can result in either hydroxylation or epoxidation, depending upon the position of the double bond(s) in relation to the terminal methyl carbon [19] .
Oxidation towards the carboxylate group: P450 BSβ (CYP152A1) P450 BSβ (CYP152A1), isolated from Bacillus subtilis, is a fatty acid hydroxylase with specificity for the carboxylic acid end of the fatty acid (the α-and β-carbons adjacent to the carboxy group) [20] . Unusually, oxidation is supported not through the transfer of electrons from redox partner proteins, but rather through the use of hydrogen peroxide as an oxidant, making this enzyme a peroxygenase rather than a mono-oxygenase. This mechanism makes use of the so-called 'peroxide shunt' route in forming the active ferryl species and may contribute to the high rate of turnover observed for enzymes such as P450 BSβ [21] . The exact function of the enzyme within B. subtilis is unknown, although the degree of biochemical and structural characterization indicates that fatty acids are likely to be substrates in vivo [22] . The use of the inexpensive oxidant hydrogen peroxide also makes this enzyme an attractive target for industrial biocatalysis.
Oxidation of the methyl terminus: CYP4A1 and CYP52A21
The selective oxidation of the methyl terminus of fatty acids is a more challenging transformation than in-chain methylene oxidation, as the oxidation is more energetically demanding and the centre to be oxidized lies directly next to more easily oxidized methylene carbons [23] . The mammalian CYP4 subfamily is able to perform this oxidation with impressive degrees of selectivity obtained for oxidation of the terminal carbon atom [7] . A mechanistic explanation for this process involves a constricted channel controlling access of the substrate methyl terminus to the active-site haem. Calibration of this site using terminally halogenated fatty acids has revealed that, whereas chlorine and bromine atoms can be oxidized, iodine atoms are not oxidized, implying an access tunnel with a diameter between 3.9 and 4.3 Å (1 Å = 0.1 nm) for CYP4A1 [24] . The fungal P450 CYP52A21, another fatty acid terminal methyl hydroxylase, has also been investigated using this technique with similar results, albeit that the iodine terminally substituted fatty acid is oxidized to a minor extent in this system [25] .
Oxidation at the centre of the chain: P450 BioI (CYP107H1) Cytochrome P450 BioI (CYP107H1) is a biosynthetic P450 found in the biotin operon of Bacillus subtilis [26] . The role of P450 BioI is the biosynthesis of pimelic acid, a C 7 diacid, formed via the oxidation of a long-chain fatty acid [26] . Initial postulates for the mechanism of P450 BioI included ω-(methyl)-hydroxylation of fatty acids followed by chainshortening reactions [27, 28] or via direct in-chain cleavage of the fatty acid [29] . Turnover data for long-chain fatty acids indicated that pimelic acid was indeed a direct product of P450 BioI -mediated fatty acid oxidation, albeit at low levels [29] . The vast majority of oxidation observed formed fatty acids hydroxylated towards the methyl terminus of the fatty acid chain, with a similar type of product distribution to P450 BM3 in terms of both regiochemistry and stereochemistry [30] . Importantly, no ω-hydroxylated product was found in any turnovers of long-chain fatty acids, which argued against the first postulate for the mechanism of pimelic acid formation. The identities of the products of oxidation were confirmed by analysis with chemically synthesized standards, thus removing any potential ambiguity in the assignment of the positions oxidized in the fatty acid chain. Incubation of synthetic fatty acid intermediates bearing oxidation at the centre of the fatty acid chain also indicated that an in-chain cleavage mechanism was consistent with alcohol/vic-diol intermediates that then undergo cleavage to two aldehydes [31] .
Pimelic acid production by P450 BioI

P450 BioI binds an ACP (acyl-carrier protein)-bound substrate in vitro
Acyl-ACP had originally been identified as a potential substrate for P450 BioI when the overexpression of P450 BioI in Escherichia coli afforded moderate amounts of ACP-bound P450 BioI complex in addition to free P450 BioI [29] . Turnover of the isolated P450 BioI -acyl-ACP complex was supported under the same conditions as unbound fatty acid turnover, with the sole product ACP-bound pimelic acid (identified following base cleavage from the ACP thiol and MS analysis). This gave further support to the hypothesis that P450 BioI oxidized fatty acids via an in-chain mechanism, and also that the possible substrates were likely to be ACP-bound, rather than unbound, fatty acids [29] .
The P450 BioI -ACP complex can be reconstituted in vitro
To gain further insights into the P450 BioI -ACP complex, it was important to be able to recreate the complex with specific fatty acids in vitro. Reconstitution of the P450 BioI -ACP complex in vitro was successfully achieved via the incubation of P450 BioI with various acyl-ACPs, which had been prepared in a two-step process from apo-ACP. This process made use of E. coli ACP synthase to form the holo-ACP using CoA, followed by acyl-ACP synthase that loaded various fatty acids in the presence of ATP. Formation of the acyl-ACPs was determined by MS and denaturing PAGE analysis, with the purification of the complex performed using a two-step affinity purification protocol taking advantage of the presence of different affinity tags on each protein [32] . Secondary features are labelled and a selection is highlighted in colour for clarity. The phosphopantetheine linker and fatty acid are shown as blue sticks, with the haem shown as red sticks. The active site of P450 BioI contains the conserved acid-alcohol residue pair responsible in P450s for controlling oxygen activation during the P450 active cycle [34] . These residues, Glu 238 and Thr 239 , are found in a kink in the I-helix above the active-site haem moiety (see Figure 3B) . The haem thiolate ligand (Cys 345 ), responsible for the important chemistry that P450s are capable of catalysing, is present in the N-terminal loop before the L-helix.
Structural analysis of the P450 BioI -ACP complex
The structure of the P450 BioI -ACP complex was determined, using single anomalous diffraction of seleneomethionine labelled crystals, for tetradecanoic acid, hexadec-(9Z)-enoic acid and octadec-(9Z)-enoic acid fatty acyl-ACPs (PDB codes 3EJB, 3EJD and 3EJE respectively) [32] . P450 BioI displays the canonical P450 fold, possessing primarily α-helical secondary structure, with some important alterations in the so-called SRSs (substrate-recognition sites) when compared with similar P450 structures [33] . These include differences in the β-1 sheet (SRS 5), the loop between helices B and B 2 (SRS 1) and the loop region between the F-and Ghelices (SRSs 2 and 3), which together form the entry tunnel for the fatty acid and the attached prosthetic linker of ACP to access the active site (Figure 2) .
Fatty acid substrates are bound in the active site of P450 BioI in a U-conformation, with the region of closest approach to the haem being the C-7 and C-8 carbons of the fatty acid chain [average carbon atom-haem iron distances for C-7 (4.3 ± 0.3 Å ) and for C-8 (4.7 ± 0.5 Å )]. This unusual conformation is enforced by a series of large hydrophobic residues that line the binding pocket ( Figure 3B ). Ile 169 is particularly notable, as this residue provides a pivot point directly above the haem iron, forcing the fatty acid to adopt a conformation appropriate for oxidation. Accommodation for the methyl termini of fatty acid chains is provided in a large hydrophobic cavity predominantly formed by residues of the F-, G-and I-helices. The size of this cavity is such that the methyl termini of fatty acids greater than 16 carbons in length are no longer visible in the electron density due to conformational mobility, with this structural feature allowing ACP-bound fatty acids of various lengths to be utilized as substrates by P450 BioI [32] .
The prosthetic phosphopantetheine linker of ACP, to which the fatty acid is bound, plays a crucial role in orienting the fatty acid appropriately for oxidation. The amide nitrogen and carbonyl oxygen atoms form hydrogen bonds with various P450 BioI side chain or backbone atoms, whereas the phosphate and alcohol moieties are involved in numerous water-mediated hydrogen-bonding interactions with P450 BioI . The presence of the linker allows the fatty acid to be positioned such that the two atoms above the haem are the required C-7 and C-8 carbons by forming the particular hydrogen-bonding pattern that it adopts. Such interactions are crucial given that the highly hydrophobic pocket surrounding the haem has no hydrogen-bonding interactions with the fatty acid carboxyl oxygen ( Figure 3A) .
The ACP molecule forms protein-protein interactions with P450 BioI , with the majority of interactions occurring through the interaction of acidic residues of ACP with basic residues of P450 BioI , or the interaction of backbone amide nitrogen and carbonyl oxygen atoms ( Figure 3C ). The structure of the P450-bound ACP molecule is little altered from the structure of apo-ACP [35] , with the exception of the post-translationally modified serine residue (Ser 57 ACP ) that rotates to allow the linker and bound fatty acid to project into the core of P450 BioI .
Structural comparisons
The binding of the ACP-bound fatty acid in P450 BioI is clearly different to that observed in the crystal structures of the fatty acid hydroxylases P450 BM3 and P450 BSβ , although both of these enzymes also share (somewhat unsurprisingly) a largely hydrophobic active-site pocket ( Figure 3D ). The electrostatic interactions of hexadec-(9Z)-enoic acid and P450 BM3 involve the carbonyl oxygen of the fatty acid and the phenol of Tyr 51 BM3 (PDB code 1FAG) [36] . Addition of a β-glycine unit to the fatty acid carboxy group results in a much tighter interaction with P450 BM3 , which is mediated through additional interactions of the glycine carboxy group with the backbone amide nitrogens of residues Gln 73 BM3 and Ala 74 BM3 (PDB code 1JPZ) [37] . The binding of fatty acids in P450 BSβ occurs in essentially the opposite orientation to that seen in P450 BM3 , with the carboxylic acid moiety located very close to the haem iron (PDB code 1IZO) [22] . Electrostatic interactions of the substrate with the P450 are achieved through the interaction of the guanidinium group of Arg 242 BSβ with the carboxy group of the fatty acid. Examining the conformations of the three fatty acid substrates in the overlaid P450s shows that the fatty acids in both P450 BM3 and P450 BSβ adopt an orientation that is essentially parallel to the haem, in contrast with P450 BioI , which utilizes a distinct U-conformation.
Implications for other P450 systems
CP-bound substrates have been either indicated or postulated for a number of other P450s, the majority of which occur in biosynthetic operons of medicinally important natural products. The oxidation of CP-bound amino acid residues have been shown to occur in the biosynthesis of the antibiotic novobiocin, where the CP domain of the nonribosomal peptide synthase NovH presents tyrosine for hydroxylation by P450 NovI [38] . Similar CP-P450 systems are present in the biosynthesis of hydroxylated amino acid precursors for several further aminocoumarin antibiotics [39] [40] [41] , the nikkomycins [42] and also the vancomycin antibiotics [43] . Another group of P450s acting upon CPbound substrates are found in the biosyntheses of the vancomycin-and teicoplanin-type glycopeptide antibiotics [44, 45] , where CP domains bearing the biosynthesized peptides undergo P450-mediated phenolic coupling of select aromatic side chains of the peptide amino acid residues [46, 47] . The biosyntheses of these compounds require three and four of these phenolic coupling steps respectively, with the reactions occurring upon the peptide bound to the sixth or seventh CP domains of the non-ribosomal peptide synthases [48] . The phenolic coupling catalysed by the first phenolic coupling P450 in the biosynthesis of vancomycin, P450 OxyB , has been demonstrated to occur upon CP-bound substrate, with turnover and binding both facilitated by the presence of the CP as a scaffold for oxidation [49] . The medicinal relevance of these compounds makes the characterization of these phenolic coupling P450-CP systems one of clear importance for the future.
